Combined Use of Immunohistochemical Markers of Basal and Luminal Subtypes in Urothelial Carcinoma of the Bladder: Association With Clinicopathological Features and Outcomes. Clinics 2022, 76, e2587. https://doi.org/10.6061/clinics/2021/e2587.